Synergistic Corona Virus Treatment System

A comprehensive system integrating compounds represented by Formula I with AI, IoT, blockchain, and nanocarrier technologies to revolutionize the treatment and management of coronavirus-associated diseases.

The original patent disclosed compounds and compositions useful for treating coronavirus-associated diseases, such as COVID-19. However, these treatments have limitations in terms of dosing, efficacy, and patient monitoring. The present inventive concept addresses these limitations by combining the patented compounds with advanced technologies to create a more powerful and effective system.

The synergistic system comprises a compound represented by Formula I, wherein R1-R6 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, and carbonyl. The system also includes a machine learning module trained to predict optimal dosages of the compound based on patient data, an IoT sensor network for real-time monitoring, a blockchain-based platform for secure data storage and sharing, and a nanocarrier system for targeted delivery of the compound. The AI-powered analytics module integrates data from various sources to identify patterns and trends, enabling personalized treatment and optimized outcomes.

The new claims introduce the concept of integrating the patented compounds with AI, IoT, blockchain, and nanocarrier technologies, which is not obvious from the original patent. The inventive step lies in the synergistic combination of these technologies to create a more effective and efficient system for treating coronavirus-associated diseases.

Alternative embodiments of the inventive concept may include different AI algorithms, IoT sensor configurations, blockchain platforms, or nanocarrier materials. Variations may also include the integration of additional technologies, such as genomic analysis or telemedicine platforms, to further enhance the system's capabilities.

The synergistic corona virus treatment system has significant commercial potential in the pharmaceutical, healthcare, and biotechnology industries. The system's ability to provide personalized treatment, real-time monitoring, and optimized outcomes positions it for widespread adoption in the global market, with potential applications in hospitals, clinics, and research institutions.